Jing Liao (Yan Wu)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Smoking Cessation

Resistance Training

Pluripotent Stem Cells

Top Venues

Hepatology international

Cellular oncology (Dordrecht)

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Liu, Yeling Ouyang, Zijin Xia, Wenhao Mai, Hongrui Song, Fang Zhou, Lichun Shen, Kaiting Chen, Xiaochen Li, Shi-Min Zhuang, Jing Liao
FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC. Cellular oncology (Dordrecht) (2023)
Diyuan Xue, Benjamin Moon, Jing Liao, Jingya Guo, Zhuangzhi Zou, Yanfei Han, Shuaishuai Cao, Yang Wang, Yang-Xin Fu, Hua Peng
A tumor-specific pro-IL-12 activates preexisting cytotoxic T cells to control established tumors. Science immunology 7 (67) (2022)
Jing Liao, Dan-Ni Zeng, Jin-Zhu Li, Qiao-Min Hua, Zhiyu Xiao, Chuanchao He, Kai Mao, Ling-Yan Zhu, Yifan Chu, Wei-Ping Wen, Limin Zheng, Jing Liao
Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma. Hepatology international 14 (1) (2019)